Thomas Karagkounis

Dr. Thomas Karagkounis

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SSSoukouli Soukouli
Soukouli Soukouli
TKThomas Karagkounis
Thomas Karagkounis
KMKonstantinos S. Mylonas
Konstantinos S. Mylonas
TKTheofanis Kalathas
Theofanis Kalathas
Kalliopi-Anna PouliaKalliopi-Anna Poulia
Kalliopi-Anna Poulia
Smaragdi MarinakiSmaragdi Marinaki
Smaragdi Marinaki
Background: Sarcopenia and sarcopenic obesity are increasingly recognized in kidney transplant recipients (KTRs), yet their molecular underpinnings remain poorly defined. We sought to synthesize current evidence on biomarker associations with muscle loss and function in the post renal transplant setting. Methods: A comprehensive search of PubMed/MEDLINE and Cochrane databases was conducted according to PRISMA guidelines. Studies evaluating biomarkers related to sarcopenia or sarcopenic obesity in adult and pediatric KTRs were included. Quality assessment was performed with the NHLBI tool. Results: Seven studies were included, encompassing 548 KTRs. Myostatin levels predicted sarcopenia in KTRs (cut-off: 390 pg/mL) and inversely correlated with Metabolic equivalent of Tasks (METs), handgrip strength (HGS), and graft performance. Although adiponectin was negatively correlated with body fat, its high-molecular-weight isoform was linked to lower muscle mass and long-term graft decline. Leptin was associated with sarcopenic obesity and lower estimated Glomerular Filtration Rate (eGFR). Insulin like Growth Factor-1 (IGF-1) independently predicted HGS but not muscle mass. Brain-derived neurotrophic factor (BDNF) levels predicted sarcopenia (cut off: 17.8 ng/mL) and reflected physical activity levels. Visfatin showed no association with sarcopenia but it was positively correlated with eGFR. Lastly, certain polymorphisms of Alpha-actinin-3 (ACTN3) were shown to genetically predispose to post-transplant sarcopenia. Conclusions: These emerging candidate biomarkers provide promising mechanistic insight into post-transplant muscle decline and may ultimately support more personalized risk assessment. Further validation is needed, and functional measures remain the most reliable clinical tools at present.

4 April 2026 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Closed access
NSNikolaos Christos Schizas
Nikolaos Christos Schizas
TKThomas Karagkounis
Thomas Karagkounis
IZIoannis Zoupas
Ioannis Zoupas
SSofia Sarantou
Sofia Sarantou
GNGeorgia Nazou
Georgia Nazou
DIDimitrios C Iliopoulos
Dimitrios C Iliopoulos
Objective: Minimally invasive techniques represent a safe alternative to full sternotomy in proximal aortic surgery. This meta-analysis evaluates their efficacy in aortic root, ascending aortic, and aortic arch procedures compared with the conventional approach. Methods: A PRISMA-compliant systematic review and meta-analysis of matched cohorts was conducted, comparing minimally invasive surgery with full sternotomy. MEDLINE was searched for eligible studies. Continuous variables were analyzed using standardized mean differences and categorical data with odds ratios. Kaplan–Meier-derived individual patient data were used to assess survival. Subgroup analysis for elective cases was performed. Results: Seventeen studies with 3113 matched patients were included. Mean age was 58.1 ± 13.3 years for minimally invasive group versus 58.1 ± 12.8 years in full-sternotomy group (p = 0.29). Postoperative blood loss (612.5 versus 883.2 mL, p < 0.01), number of red blood cell units transfused (1.0 versus 2.2, p < 0.01) and postoperative ventilation time (15.3 versus 19.2 h, p < 0.01) were significantly lower in the minimally invasive group. Similarly, overall hospital (8.4 versus 9.4 days, p < 0.01) and intensive care unit stay (1.5 versus 1.8 days, p < 0.01) were decreased in minimally invasive group. Overall survival was significantly improved in minimally invasive patients (Hazard Ratio: 0.54, p = 0.045), which was not confirmed by two-stage meta-analysis (Hazard Ratio: 0.72, p = 0.29). Bypass and cross-clamp times, reinterventions, bleeding events and wound infections were comparable between the two groups. Conclusion: Minimally invasive proximal aortic surgery reduces perioperative morbidity, hospitalization and transfusion requirements compared with full sternotomy. While a survival benefit requires further confirmation, these findings support minimally invasive approaches as an effective and safe alternative in selected patients.

Verified
Journal Article
Open access
PDF file
AAAngeliki Alifragki
Angeliki Alifragki
VKVasiliki Katsi
Vasiliki Katsi
KFKonstantinos Fragkiadakis
Konstantinos Fragkiadakis
TKThomas Karagkounis
Thomas Karagkounis
NKNikolaos Kopidakis
Nikolaos Kopidakis
Maria E. MarketouMaria E. Marketou
Maria E. Marketou
Heart Failure with Preserved Ejection Fraction (HFpEF) is an increasingly prevalent clinical syndrome that poses a significant public health challenge due to its complex pathophysiology, diagnostic limitations, and lack of effective therapies. Central to its development are multifactorial and interrelated mechanisms, including left ventricular diastolic dysfunction, myocardial fibrosis, inflammation, endothelial dysfunction, and cardiomyocyte hypertrophy. In recent years, noncoding RNAs (ncRNAs)—particularly microRNAs (miRNAs) and long noncoding RNAs (LncRNAs)—have emerged as critical regulators of these cellular and molecular pathways. This review outlines the major pathophysiological mechanisms underlying HFpEF and highlights the noncoding RNAs most extensively studied in this context. Several ncRNAs have shown promise as biomarkers for the diagnosis and prognosis of HFpEF, owing to their tissue specificity, stability in circulation, and involvement in disease-relevant pathways. However, their integration into routine clinical practice remains limited. Importantly, the regulatory functions of ncRNAs in HFpEF pathophysiology also position them as potential therapeutic targets. Early experimental studies demonstrate encouraging results, suggesting that ncRNA-targeted interventions may support the development of personalized treatment strategies tailored to the diverse clinical phenotypes observed in HFpEF.

Verified
Journal Article
Open access
PDF file
TKThomas Karagkounis
Thomas Karagkounis
AAAngeliki Alifragki
Angeliki Alifragki
IZIoannis Zoupas
Ioannis Zoupas
SSofia Sarantou
Sofia Sarantou
NSNikolaos Christos Schizas
Nikolaos Christos Schizas
DIDimitrios ILIOPOULOS
Dimitrios ILIOPOULOS
Background/Objectives: Minimally invasive (MIS) mitral valve surgery has been proven to be a safe and effective alternative to median sternotomy (ST), with advantages in postoperative recovery and morbidity. However, its role in the setting of infective endocarditis (IE) remains uncertain. This meta-analysis aims to evaluate the outcomes of MIS in mitral valve surgery for infective endocarditis. Methods: A PRISMA-compliant search for studies including patients undergoing MIS for mitral valve IE was performed through 14 January 2026, in PubMed, Scopus and Cochrane. Time-to-event data were reconstructed from published Kaplan–Meier curves. A secondary comparative analysis focusing on MIS versus ST techniques was conducted. Results: Fourteen retrospective studies comprising 949 patients were analyzed. In the MIS cohort, early mortality was 4.2% (95%CI: 1.8%, 7.4%). Overall survival was 86.7% at 1 year, 75.2% at 5 years and 56.2% at 10 years. Freedom from IE-related reoperation remained high at 97.5%, 95.9%, and 90.7% at 1, 5, and 10 years, respectively. Mitral valve repair was performed in 52.5% of patients. In secondary comparative analyses, overall survival at 4-year follow-up was not different between MIS and ST [HR: 0.82 (95%CI: 0.43, 1.57), p = 0.55]. MIS was associated with a significantly shorter intensive care unit (ICU) stay [MD: −1.52 days (95%CI: −2.08, −0.97), p < 0.01]. Conclusions: MIS for mitral valve IE is associated with favorable early and long-term outcomes, comparable survival with sternotomy, and reduced ICU stay. These findings suggest that MIS may be considered as a feasible and potentially effective alternative for the management of mitral valve IE in carefully selected patients. Further prospective comparative studies are warranted.

1 March 2025 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Closed access
PKParis Dimitrios Kalogerakos
Paris Dimitrios Kalogerakos
TKThomas Karagkounis
Thomas Karagkounis
JKJohn Konstantinou
John Konstantinou
LLLambros Lazopoulos
Lambros Lazopoulos
ECEvangelia Chryssou
Evangelia Chryssou
GLGeorge Lazopoulos
George Lazopoulos
Traumatic ascending aortic rupture has been firmly associated with blunt thoracic trauma. Adding to the current understanding, we report a case of a patient without signs of external thoracic collision, who suffered a contained aortic rupture just distally of the sinotubular junction, due to severe blunt abdominal trauma. The increased intra-abdominal pressure ruptured the left hemidiaphragm and, presumably, led to the abrupt angulation and rupture of the proximal ascending aorta, sparing the rest of the aorta and the heart. The patient underwent an uneventful urgent aortic repair with a tubular graft, without total circulatory arrest. After a prolonged hospital stay, he was discharged.

17 August 2025 in Medical Sciences
Verified
Journal Article
Open access
PDF file
ENEvangelia Ntikoudi
Evangelia Ntikoudi
TKThomas Karagkounis
Thomas Karagkounis
KMKonstantinos S. Mylonas
Konstantinos S. Mylonas
Stylianos KykalosStylianos Kykalos
Stylianos Kykalos
DIMITRIOS SCHIZASDIMITRIOS SCHIZAS
DIMITRIOS SCHIZAS
Stamatios TheocharisStamatios Theocharis
Stamatios Theocharis
Background/Objectives: PROX1 (prospero homeobox 1) is a transcription factor involved in lymphangiogenesis and cellular differentiation. Its role in cancer biology appears to be highly context-dependent, with it exhibiting both tumor-promoting and -suppressive functions across various malignancies. Nonetheless, the clinical significance of PROX1 expression in non-small cell lung cancer (NSCLC) remains poorly elucidated. The objective of this study is to evaluate the immunohistochemical expression of PROX1 in NSCLC, specifically in the adenocarcinoma and squamous cell carcinoma subtypes, and to assess its correlation with clinicopathologic features and overall survival (OS). Methods: This retrospective study included surgically resected specimens from 121 patients with histologically confirmed NSCLC. PROX1 expression was assessed via immunohistochemistry on formalin-fixed, paraffin-embedded specimens. Staining intensity (graded 0– National and Kapodistrian University of Athens 3) and the percentage of positive tumor cells were recorded. Correlations with histological subtype, tumor characteristics, and OS were analyzed using chi-square tests, one-way ANOVA, and Kaplan–Meier survival analysis with log-rank testing. Results: Low PROX1 intensity (level 1) was significantly associated with P63 positivity (p = 0.028), while high PROX1 intensity (level 3) correlated with nodal metastasis to station 3 (S3+) (p = 0.025). Additionally, alveolar-pattern adenocarcinomas exhibited intermediate PROX1 expression (26–50%) (p = 0.010). Although PROX1 positivity did not differ among mucinous and non-mucinous adenocarcinomas (p = 0.152), its distribution across defined expression subgroups was statistically significant (p = 0.002). Tumors with low PROX1 expression (0–24%) were associated with a larger maximum tumor diameter (p = 0.026). PROX1 expression was not independently associated with OS (p > 0.05). Factors significantly associated with improved survival included an age < 50 years, female sex, the absence of necrosis, fewer than 10 positive lymph nodes, a lymph node ratio < 0.5, and the absence of extensive nodal involvement in stations 5, 10, 11, and 12. Conclusions: Although PROX1 expression is variably associated with specific histologic subtypes and nodal metastases in NSCLC, it does not independently predict overall survival. Its expression patterns suggest a potential role in tumor differentiation and lymphatic spread. Further mechanistic and immunologic studies are warranted to elucidate the functional significance of PROX1 in lung cancer biology.